Professional Documents
Culture Documents
Information Collection Statement eLibrary in PDF and Microsoft Word 2601–2645; 28 U.S.C. 2461; 31 U.S.C. 3701,
format for viewing, printing, and/or 9701; 42 U.S.C. 7101–7352; 49 U.S.C. 60502;
9. The Office of Management and 49 App. U.S.C. 1085 (1988).
Budget’s (OMB’s) regulations require downloading. To access this document
in eLibrary, type the docket number ■ 2. Section 385.203 is amended by
that OMB approve certain information
excluding the last three digits of this revising paragraph (a)(7) to read as
collection requirements imposed by
document in the docket number field. follows:
agency rule. 5 CFR 1320.12 (2005). This
Final Rule contains no additional 14. User assistance is available for
§ 385.203 Content of pleadings and tariff
information reporting requirements, and eLibrary and the FERC’s Web site during or rate filings (Rule 203).
is not subject to OMB approval. normal business hours. For assistance,
(a) * * *
please contact the Commission’s Online
Environmental Analysis (7) The position taken by the
Support at 1–866–208–3673 (toll free) or
participant filing any pleading, to the
10. The Commission is required to 202–502–6652 (e-mail at
extent known when the pleading is
prepare an Environmental Assessment FERCOnlineSupport@ferc.gov) or the
filed, and the basis in fact and law for
or an Environmental Impact Statement Public Reference Room at (202) 502–
such position;
for any action that may have a 8371, TTY (202) 502–8659. E-Mail the
Public Reference Room at * * * * *
significant adverse effect on the human
public.referenceroom@ferc.gov. ■ 3. Section 385.713 is amended by
environment.7 The Commission has
categorically excluded certain actions revising paragraph (c)(2) to read as
Effective Date follows:
from this requirement as not having a
significant effect on the human 15. These regulations are effective
§ 385.713 Request for rehearing (Rule
environment. Included in the exclusion immediately upon publication in the 713).
are rules that are clarifying, corrective, Federal Register. In accordance with 5
U.S.C. 553(d)(3), the Commission finds * * * * *
or procedural that do not substantially (c) * * *
change the effect of the regulations that good cause exists to make this Final
(2) Conform to the requirements in
being amended. This rule is procedural Rule effective immediately upon
Rule 203(a), which are applicable to
in nature and, therefore, falls under this publication. It concerns only a matter of
pleadings, and, in addition, include a
exception; consequently, no procedure eliminating a requirement
separate section entitled ‘‘Statement of
environmental consideration is affecting formatting of filings.
Issues,’’ listing each issue in a
necessary. 16. The provisions of 5 U.S.C. 801
separately enumerated paragraph that
regarding Congressional review of Final
Regulatory Flexibility Act Certification includes representative Commission
Rules does not apply to this Final Rule,
and court precedent on which the party
11. The Regulatory Flexibility Act of because the rule concerns agency
is relying; any issue not so listed will be
1980 (RFA) 8 generally requires a procedure and practice and will not
deemed waived; and
description and analysis of final rules substantially affect the rights of non-
agency parties. * * * * *
that will have significant economic
17. The Commission is issuing this as [FR Doc. 06–2800 Filed 3–22–06; 8:45 am]
impact on a substantial number of small
entities. The Commission is not a final rule without a period for public BILLING CODE 6717–01–P
required to make such analysis if a rule comment. Under 5 U.S.C. 553(b), notice
would not have such an effect. The and comment procedures are
Commission certifies that this rule will unnecessary where a rulemaking DEPARTMENT OF HEALTH AND
not have such an impact on small concerns only agency procedure and HUMAN SERVICES
entities as it merely clarifies existing practice, or where the agency finds that
requirements. An analysis under the notice and comment is unnecessary. Food and Drug Administration
RFA, therefore, is not required. This rule concerns only a clarification of
a matter of agency procedure and will 21 CFR Part 520
Document Availability not significantly affect regulated entities
or the general public. Oral Dosage Form New Animal Drugs;
12. In addition to publishing the full
Orbifloxacin
text of this document in the Federal List of Subjects in 18 CFR Part 385
Register, the Commission provides all AGENCY: Food and Drug Administration,
interested persons an opportunity to Administrative practice and HHS.
view and/or print the contents of this procedure, Electric utilities, Penalties, ACTION: Final rule.
document via the Internet through Pipelines, Reporting and recordkeeping
FERC’s Home Page (http://www.ferc.gov) requirements. SUMMARY: The Food and Drug
under ‘‘What’s New’’ and in FERC’s By the Commission. Administration (FDA) is amending the
Public Reference Room during normal Magalie R. Salas, animal drug regulations to reflect
business hours (8:30 a.m. to 5 p.m. Secretary.
approval of a supplemental new animal
Eastern time) at 888 First Street, NE., drug application (NADA) filed by
Room 2A, Washington, DC 20426. ■ In consideration of the foregoing, the Schering-Plough Animal Health Corp.
13. From FERC’s Home Page on the Commission amends part 385, Chapter I, The supplemental NADA provides for
Internet, this information is available in Title 18, Code of Federal Regulations, as revised animal safety labeling for
the Commission’s document follows. orbifloxacin tablets used in dogs and
management system, eLibrary. The full cats for the management of diseases
PART 385—RULES OF PRACTICE AND
text of this document is available on associated with susceptible bacteria.
PROCEDURE
rmajette on PROD1PC67 with RULES
VerDate Aug<31>2005 13:41 Mar 22, 2006 Jkt 208001 PO 00000 Frm 00014 Fmt 4700 Sfmt 4700 E:\FR\FM\23MRR1.SGM 23MRR1
Federal Register / Vol. 71, No. 56 / Thursday, March 23, 2006 / Rules and Regulations 14643
Administration, 7500 Standish Pl., § 520.1616 Orbifloxacin. IV. Summary and Disposition of Comments
Rockville, MD 20855, 301–827–7543, e- (a) Specifications. Each tablet V. OSM’s Decision
mail: melanie.berson@fda.hhs.gov. contains 5.7, 22.7, or 68 milligrams (mg) VI. Procedural Determinations
part 520 continues to read as follows: SUPPLEMENTARY INFORMATION: WY–038–4). We did not hold a public
I. Background on the Wyoming Plan hearing or meeting because no one
Authority: 21 U.S.C. 360b.
II. Submission of the Proposed Amendment requested one. The public comment
■ 2. Revise § 520.1616 to read as III. Office of Surface Mining Reclamation and period ended on December 29, 2005. We
follows: Enforcement’s (OSM) Findings did not receive any comments.
VerDate Aug<31>2005 13:41 Mar 22, 2006 Jkt 208001 PO 00000 Frm 00015 Fmt 4700 Sfmt 4700 E:\FR\FM\23MRR1.SGM 23MRR1